In this work, we analyze human germline and tumor data, and perform molecular and cellular studies in mouse models with conditional overexpression of HMMR and loss of BRCA1 and p53 in mammary epithelial cells, to decipher the biological foundation of increased risk of BRCA1-associated breast cancer. The gene discussed is TP53; the disease is breast cancer.